De Rosa FG - Search Results

1

Pharmacokinetics of linezolid in critically ill patients: impact of continuous venovenous haemofiltration.

Corcione S, D'Avolio A, Allegra S, Fanelli V, Urbino R, Ranieri MV, Di Perri G, De Rosa FG. Corcione S, et al. Among authors: de rosa fg. Int J Antimicrob Agents. 2017 Jun;49(6):784-785. doi: 10.1016/j.ijantimicag.2017.04.002. Epub 2017 Apr 12. Int J Antimicrob Agents. 2017. PMID: 28412274 No abstract available.

2

Healthy ranges for alanine aminotransferase levels.

De Rosa FG, Bonora S, Di Perri G. De Rosa FG, et al. Ann Intern Med. 2003 Jan 21;138(2):156-7; author reply 156-7. doi: 10.7326/0003-4819-138-2-200301210-00021. Ann Intern Med. 2003. PMID: 12529101 No abstract available.

3

Detection of stavudine concentrations in plasma of HIV-infected patients taking zidovudine.

Bonora S, Boffito M, D'Avolio A, Sciandra M, Caci AM, Conta F, Sinicco A, De Rosa FG, Di Perri G. Bonora S, et al. Among authors: de rosa fg. AIDS. 2004 Feb 20;18(3):577-8. doi: 10.1097/00002030-200402200-00031. AIDS. 2004. PMID: 15090817 No abstract available.

4

Dose-dependent and genotype-independent sustained virological response of a 12 week pegylated interferon alpha-2b treatment for acute hepatitis C.

De Rosa FG, Bargiacchi O, Audagnotto S, Garazzino S, Cariti G, Raiteri R, Di Perri G. De Rosa FG, et al. J Antimicrob Chemother. 2006 Feb;57(2):360-3. doi: 10.1093/jac/dki458. Epub 2006 Jan 5. J Antimicrob Chemother. 2006. PMID: 16396921

5

Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient.

De Rosa FG, Audagnotto S, Bargiacchi O, Garazzino S, Aguilar Marucco D, Veronese L, Canta F, Bonora S, Sinicco A, Di Perri G. De Rosa FG, et al. J Infect. 2006 Nov;53(5):e215-8. doi: 10.1016/j.jinf.2006.01.023. Epub 2006 Mar 20. J Infect. 2006. PMID: 16549201

6

The early HCV RNA dynamics in patients with acute hepatitis C treated with pegylated interferon-alpha2b.

De Rosa FG, Bargiacchi O, Audagnotto S, Garazzino S, Cariti G, Veronese L, Raiteri R, Calleri G, Di Perri G. De Rosa FG, et al. Antivir Ther. 2006;11(2):165-71. Antivir Ther. 2006. PMID: 16640097

7

Acute hepatitis C: dosage and compliance.

De Rosa F, Cariti G, Di Perri G. De Rosa F, et al. Hepatology. 2006 Aug;44(2):511; author reply 511-2. doi: 10.1002/hep.21273. Hepatology. 2006. PMID: 16871564 No abstract available.

8

Continuous infusion of amphotericin B deoxycholate: does decreased nephrotoxicity couple with time-dependent pharmacodynamics?

de Rosa FG, Bargiacchi O, Audagnotto S, Garazzino S, Ranieri VM, di Perri G. de Rosa FG, et al. Leuk Lymphoma. 2006 Sep;47(9):1964-6. doi: 10.1080/10428190600687133. Leuk Lymphoma. 2006. PMID: 17065014 Review. No abstract available.

9

Twelve-week treatment of acute hepatitis C virus with pegylated interferon- alpha -2b in injection drug users.

De Rosa FG, Bargiacchi O, Audagnotto S, Garazzino S, Cariti G, Calleri G, Lesioba O, Belloro S, Raiteri R, Di Perri G. De Rosa FG, et al. Clin Infect Dis. 2007 Sep 1;45(5):583-8. doi: 10.1086/520660. Epub 2007 Jul 19. Clin Infect Dis. 2007. PMID: 17682992 Clinical Trial.

10

SPIR01 and SPIR02: a two-year 1-day point prevalence multicenter study of infections in intensive care units in Piedmont, Italy.

De Rosa FG, Garazzino S, Audagnotto S, Bargiacchi O, Zeme DA, Gramoni A, Barberis B, Ranieri VM, Di Perri G; Piedmont Intensive Care Unit Network. De Rosa FG, et al. New Microbiol. 2008 Jan;31(1):81-7. New Microbiol. 2008. PMID: 18437845 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

366 results

Search Page

Filters